Ga direct naar de inhoud

Ga direct naar de navigatie

Uitgave van

Archief voor de categorie ‘Farma ondernemingen’

Kallyope and Novo Nordisk announce obesity and diabetes collaboration

Kallyope and Novo Nordisk have entered into a research collaboration and option agreement to discover novel peptide therapeutics for the treatment of obesity and diabetes.

Bron: Meer lezen »

Latecomer Sanofi looks to catch next wave of cancer therapies

Sanofi missed the boat on immune system-boosting cancer drugs. Now it’s trying to catch up.

Bron: Reuters Health Meer lezen »

J&J looks to trim business with $2.8bn sale

Johnson & Johnson continues to look at options to slim down its business, after having received an offer from Fortive to sell its medical-sterilisation unit for $2.8 billion.

Bron: Pharmafile Meer lezen »

Pfizer pumps $600m into venture fund, targeting neuroscience

Pfizer’s move to dump it’s neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an end of big pharma’s interest in the notoriously difficult to target disease area, which includes the illusive targets of Alzheimer’s and Parkinson’s disease.

Bron: Pharmafile Meer lezen »

Apple lanceert API voor gezondheidsdata

Apple lanceert dit najaar een API om ontwikkelaars toegang te geven tot gezondheidsdata. Gegevens van zeker 500 ziekenhuizen kunnen dan gedeeld worden.

Bron: Meer lezen »

FDA approves lower dose of Lilly-Incyte arthritis drug

The U.S. Food and Drug Administration approved the lower dose of a rheumatoid arthritis drug developed by Eli Lilly and Incyte Corp, but declined to approve its higher and more lucrative dose.

Bron: Reuters Meer lezen »

The Pfizer Foundation announces $5 million in grants to support women and families

The Pfizer Foundation announced a new $5 million grant commitment to initiatives in low- and middle-income countries that provide family planning access and education for women and men at the same time children are routinely vaccinated.

Bron: World Pharma News Meer lezen »

Sanofi concentreert Nederlandse activiteiten in Amsterdam

Sanofi sluit zijn vestigingen in Gouda en Naarden. De Franse farmaceut huisvest alle activiteiten en medewerkers in dit land voortaan op één locatie in Amsterdam, schrijft Het Financieele Dagblad.

Bron: Skipr Meer lezen »

Allergan aims to appease investors with non-core units sell off

Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated with the drugmaker’s attempts to turn it around.

Bron: Pharmafile Meer lezen »

ViiV’s two-drug regimen gets EU approval for HIV-1

ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the European Commission, making it the first available two-drug regimen, daily single pill solution for the type 1 of the virus (HIV-1).  

Bron: Pharmafile Meer lezen »

« Oudere artikelen |